Open Access2078 Can Dosing Intervals of Adalimumab Be Increased in Crohn’s Disease?
Author(s) -
Lindsay Euers,
Kerri Glassner,
Amanda Wilhite,
Bincy Abraham
Publication year - 2019
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000597844.22128.48
Subject(s) - adalimumab , medicine , dosing , crohn's disease , gastroenterology , infliximab , colonoscopy , inflammatory bowel disease , tumor necrosis factor alpha , disease , colorectal cancer , cancer